Skip to content
Summer 2026 · 26% off every plan with SUMMER26 See pricing
Optionomics
NVEC · 10-Q filed July 22, 2026

NVEC earnings analysis

What we found in NVEC's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.

Our reading of the filing · Free to read, no account needed

NVE reported strong first-quarter fiscal 2027 operating momentum: revenue rose 80.7% year over year, gross margin improved 70 basis points to 81.3%, and operating margin expanded 400 basis points to 65.9%. Product sales, which were 97.3% of revenue, grew 81.7%, while contract R&D grew 52.7%; net income rose 78.8%. Operating cash flow of $5,306,318 and just $56,833 of capex supported calculated free cash flow of $5,249,485, although receivables rose $3,136,772 and dividends consumed $4,837,166. The supplied 10-Q excerpt does not provide a sequential revenue/EPS comparison or a new quantitative revenue/EPS outlook.

What stood out

The parts that mattered.

Pulled out of the filing itself, with the figures the company reported.

Revenue growth accelerated 81% year over year
Total revenue increased 80.7% year over year, driven by an 81.7% increase in product sales and a 52.7% increase in contract R&D revenue. Management attributed product growth to higher defense and non-defense sales through both direct and distributor channels.
Operating leverage expanded margins
Gross margin improved to 81.3% from 80.6% in the prior-year quarter, while operating margin expanded to 65.9% from 61.9%. Income from operations grew 92.1%, outpacing the 80.7% increase in revenue.
Net income rose 79% despite cost growth
Net income increased 78.8% year over year, despite a 49.5% increase in total operating expenses and a 9.7% decline in interest income.
Strong cash conversion and low capex
Operating cash flow was $5,306,318, and fixed-asset purchases were only $56,833, implying calculated free cash flow of $5,249,485 and capex intensity of roughly 1.1% of operating cash flow.
Cash increased despite shareholder payout
Cash and cash equivalents increased $1,182,108 to $2,896,148 at June 30, 2026, even after $4,837,166 of dividends paid during the quarter.
Capital-spending burden is set to ease
Management expects fiscal 2027 fixed-asset purchases to be significantly below fiscal 2026 levels; current-quarter fixed-asset purchases were $56,833 following completion of the prior-year expansion.
What to watch

And the other side of it.

The offsets in the same document — the things a summary that only listed the good news would have left out.

Receivables growth increases working-capital risk
Accounts receivable increased $3,136,772 during the quarter, principally because of increased sales and customer-payment timing. This absorbed a meaningful portion of the $5,306,318 operating cash inflow.
Compensation and development costs rose
Selling, general and administrative expense increased 80.5% year over year, primarily from performance-based compensation, while R&D expense increased 31.4% from staffing and new-product development.
Recurring dividends draw on liquidity
The company paid $4,837,166 in dividends during the quarter and declared another $1.00-per-share dividend totaling $4,837,166, payable August 31, 2026. Future dividends remain subject to Board approval and may be modified or discontinued.
No material risk-factor updates
Item 1A states there were no material changes to risk factors from the Form 10-K for the fiscal year ended March 31, 2026. Existing disclosed exposures include reliance on several large customers, industry economic conditions, and tariffs or other trade barriers.
The numbers

What they reported.

What the company itself reported, taken out of the document.

What survived to operating profit
Of every $100 of revenue Cost of sales $19 Operating expenses $15 Left as operating profit $66
Percentages of revenue, taken from the filing. Drawn this way because it holds whatever scale the company reports in.
Gross margin
81.3%
Operating margin
65.9%
Segment
Product sales represented 97.3% of revenue and increased 81.7% year over year.
Segment
Contract research and development represented 2.7% of revenue and increased 52.7% year over year.
Guidance

What they said about what is next.

The 10-Q contains no quantitative revenue or EPS outlook. Management expects fiscal 2027 fixed-asset purchases to be significantly lower than fiscal 2026 following completion of the expansion; it also declared a $1.00-per-share dividend payable August 31, 2026.

How we read the filing overall

The filing reads better than the one before it.

One reading of one document. It is not advice, and it is not a forecast.
Earlier filings

What came before.

10-K · May 6, 2026
NVE Corporation's FY2026 report shows a modest revenue growth of 1.8% to $26.33 million, with a gross margin decline to 78.7% from the previous year's 83.6%. Net income rose slightly by 1% to $15.2 million, driven by…
10-Q · January 21, 2026
NVE reported quarterly revenue of $6,224,776 (up 22.9% YoY) and diluted EPS of $0.70 (up from $0.63). Product sales of $5,778,674 (up 16.5%) and contract R&D of $446,102 (up 335%) drove the top-line gain, while gross…
10-Q · October 23, 2024
NVE reported quarterly revenue of $6,758,690 and diluted EPS of $0.83 for the quarter ended September 30, 2024. Gross margin expanded to 86.0% and operating margin remained very high at 65.1%, but revenue declined 5%…
10-K · May 1, 2024
NVE (NVEC) is a niche spintronics developer focused on sensors, couplers (isolators), isolated DC-to-DC converters and low-density MRAM; the 10-K emphasizes product roadmap (new coupler+DC‑DC, ultra‑high isolation…

This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.

Read the next one first.

We read every filing NVEC makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.

Cancel anytime · Month to month · Switch tiers whenever